Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Remyelination Therapy for Multiple Sclerosis.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Fine-Tuning S1P Therapeutics.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE.
The axes of access--improving care for patients with disabilities.
Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
Pediatric optic neuritis.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Multiple sclerosis: Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients.
The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
[Charcot and his legacy to medicine].
Management of optic neuritis as a clinically first event of multiple sclerosis.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

Pages